Summary.-The relationship between tumour volume response and cell kill in B16 melanoma following treatment in vivo with cyclophosphamide (CY) and 1-(2-chloroethyl)-3-cyclohexyl-1 -nitrosourea (CCNU) was investigated. Tumour volume response, expressed as growth delay, was estimated from measurements of tumour dimensions. Depression of in vitro colony-forming ability of cells from treated tumours was used as the measure of tumour cell kill. The relationship between these parameters was clearly different for the two agents studied. CY produced more growth delay (7-5 days) per decade of tumour cell kill than CCNU (2 to 3-5 days). The possibility that this was due to a technical artefact was rejected in favour of an alternative explanation that different rates of cellular repopulation in tumours treated with CY and CCNU might be responsible. Cellular repopulation was measured directly, by performing cell-survival assays at various times after treatment with doses of CY and CCNU which produced about 3 decades of cell kill. The rate of repopulation by clonogenic cells was much slower after treatment with CY than with CCNU, and this appears to account for the longer duration of the growth delay obtained with CY.
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TUMOUR volume response to cytotoxic treatment is determined by 3 main factors: the proportion of cells killed by treatment, the rate and extent of cell loss, and the rate of repopulation by tumour stem cells surviving treatment. Although cell kill may be regarded as the primary factor, without which there is unlikely to be any volume regression, differences in the rates of cellular repopulation after treatment with various agents will influence the extent of tumour volume response.
In this paper, we describe experiments designed to study the relationship between tumour volume response and cell kill in B 16 melanoma treated with cyclophosphamide (CY) and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (CCNU) . CY and CCNU were chosen for this study because they showed marked differences in behaviour in preliminary experiments performed with various chemothecrapeutic agents which produce significant e'evels of cell kill and delay in the growilth of B16 melanoma. Tumour volume resi)onse, expressed as growth delay, was followed by caliper measurements. Depression )I the in vitro colony-forming ability cf cells, obtained from treated tumouls by trypsinization, was used as the measure of cell kill. The relationship between growth delay and surviving fraction differed for the two agents studied, and the rates of cellular repopulation, after doses which produced equivalent levels of measured cell kill, were compared to see how far the observed discrepancy could be accounted for by repopulation differences. Stephens, Peacock and Steel (1977) and 0*05-ml aliquots were injected either s.c. into each flank, or i.m. into the gastrocnemius muscle of each leg. A few experiments were performed using Lewis lung carcinoma. The method of transplantation was the same as for B16 melanoma. Mice were selected for experiments when both of their tumours were within the size range 0.05 to 0-2 g.
Measurement of tumour size. Measurements of the size of s.c. and i.m. tumours were made by the calibration curve technique (Steel, Adams and Barrett, 1966) . For s.c. tumours the product of two superficial diameters was used as a measure of tumour size, and for i.m. tumours the mean of two leg diameters was used. The calibration curves were constructed by direct studies of the relationship between these measures and the weight of tumour on dissection.
Measurement of growth delay.-Tumourbearing mice were allocated randomly into groups of 7 or 8. Each animal was then earmarked and its tumours were measured. One group was selected as untreated controls and the others were treated with cytotoxic agents at a range of dose levels. Eighteen hours later 2 animals were taken at random from each group, tumour cell suspensions were prepared from the pooled tumours and cell survival was measured in vitro as described below. The remaining tumours were measured every 2 or 3 days until they were at least 4 x the size recorded on the day of drug administration. The time taken for each individual tumour to increase in size by a factor of 4 was determined (T4,). Preparation of cell suspensions.-Cell suspensions were prepared from B16 melanoma as described previously (Stephens, Peacock and Steel, 1977 Microscopic preparations of tumour cells were made using a cytocentrifuge, and stained with Giemsa.
Cell survival assay.-Survival of B16 melanoma cells was measured using the softagar-colony assay described by Courtenay (1976) and modified by Stephens et al. (1977) . Varying numbers of viable cells ranging from 500 to 104 were plated in 30-mm Petri dishes. The total number of cells plated in each dish was adjusted to about 104 by the addition of cells which had been killed by exposure to 30,000 rad of 60Co y-rays (HR cells).
Cultures were incubated for 14 to 16 days at 37°C in a water-saturated atmosphere of 500 C02, 5% 02, and 90%o N2. All colonies of more than 50 cells were counted and plating efficiency (PE) was calculated as (number of colonies scored)/(number of cells plated). At least 3 dishes were counted for each experimental point, and the standard error was usually about 500 of the mean. The PE of control B16 melanoma cells varied from 0 30 to 0 55 and of Lewis lung carcinoma, from 0415 to 0 40, over the period during which this work was done. Plating efficiencies down to 0*0005 could be measured by this method.
Response to cytotoxic agents was expressed in terms of the fraction of surviving cells per tumour. This was calculated as the product of relationships between these parameters are clearly different for CY and CCNU. The curve for CY is exponential, the growth delay being about 7*5 days for each decade reduction in cell survival. In the case of CCNU, however, there may be an upward curvature and the growth delay per decade reduction in cell survival appears to range from about 2 to 3-5 days. Similar experiments were also performed on B16 melanoma growing in the i.m. site, and on s.c. Lewis lung carcinoma. The results are shown in Fig. 4 . In both cases, CY gave a linear relationship between T4X and cell survival, whilst CCNU gave curves that were slightly concave upwards.
Cellular repopulation studies Cellular repopulation in s.c. B16 melanomas treated with CY and CCNU was studied, using the in vitro cell-survival assay. Doses of each agent were chosen which gave about equal (10-3) reductions in fraction of surviving cells per tumour 18 h after drug administration (CY 300 mg/ kg and CCNU 20 mg/kg-see Fig. 2 ). The first assay was performed 2 h after drug administration, with subsequent assays at volume Td of 3-6 days.
DISCUSSION
The present work has demonstrated that the relationship between tumourgrowth delay and the extent of cell kill, as measured by a clonogenic cell assay, depends on the cytotoxic agent used to produce damage.
In the B16 melanoma, to achieve a 10-day growth delay it was necessary to reduce clonogenic cell survival to less than 10-3 with CCNU, but only to about 10-1 with CY. In the Lewis lung tumour the difference was in the same direction but not so great. Two possible explanations may be considered. Firstly, a technical artefact may have led us to false estimates of cell survival or growth delay, and secondly, the results may reflect a difference in the rate of tumour-cell repopulation after treatment with these drugs.
It has been assumed in this work that the behaviour of cells obtained by trypsinization is representative of all cells in an intact tumour. The possibility that the PE of drug-damaged cells may be modified by trypsin cannot definitely be ruled out, the Table seem to rule out the first of these possibilities. The repair of PLD after treatment with drugs or radiation has been well described (Little et al., 1973; Hahn et al., 1973 Hahn et al., , 1974 Twentyman and Bleehen, 1975) . However, this has usually been found to be a relatively rapid process that is complete within 6 to 10 h of treatment, although, following treatment of EMT6 with CY, repair of PLD may take up to 48 h (Twentyman, 1977) . There is no evidence in the data shown in Fig. 7 for such a process occurring in B16 melanoma after CCNU. The number of clonogenic cells per tumour increased exponentially from 2 h to 10 days after treatment, with a doubling time of 20 h. This is consistent with a pure repopulation process that begins immediately after treatment. There is also no evidence for the repair of PLD after treatment of B 16 melanoma with CY (Fig. 6 , this paper; also Stephens, Peacock and Steel, 1977) . Further evidence that PLD repair does not occur after treatment with either CCNU or CY is available from the work of Hill and Stanley (1975) who found that dose-survival curves obtained 2 and 22 h after treatment of B 16 melanoma with these agents were identical. A study of the curability of i.m. implants of small numbers of B 16 melanoma cells also appears to confirm that the cellsurvival data obtained with the in vitro colony assay is representative of the in vivo situation. Groups of animals were implanted with 32 tumour cells and treated with CY and CCNU several days later.
The TCD5os (drug doses to cure 5000 of implants) for each agent, which represent doses which have reduced cell survival by the same degree, were compared. When CY and CCNU were administered 2, 3 or 6 days after implantation of tumour cells the TCD50 ratios were 8-5: 1, 10: 1 and 13'5 : 1 respectively. These ratios compare well with those calculated from the survival data presented in Fig. 2 (e.g. ranging from about 10 1 at a fractional cellsurvival level of 10-1 to about 14: 1 at 10-3). These data will be the subject of a separate publication.
Significant errors seem unlikely to arise in the assessment of growth delay by the method used here. With the exception of some tumours treated with 300 mg/kg of CY, growth rate had always returned to that of untreated tumours well before 4 x the original weight was reached. Regrowth to a larger size could not be used, because tumours began to ulcerate at about 0 5 g when treated with high doses of CY.
That the discrepancies between the results for CY and CCNU might arise from difference in rates of cellular repopulation seems much more plausible. The average rate of repopulation by surviving clonogenic cells was estimated from the data presented in Fig. 3 . The median time for tumours to quadruple in volume was divided by the estimated number of cell doublings which occurred during recovery. This number of cell doublings was estimated by assuming (1) that surviving fraction must return to unity and (2) that 2 extra doublings must be added to take account of the fact that the end-point of the experiment was a 4-fold increase in tumour volume. This calculation probably underestimates the actual number of doublings involved, for there may be some cell loss, or failure to divide, in the regrowing cell population. The Td obtained therefore represents a probable maximum value. The estimated mean Tds are plotted against the extent of cell kill in Fig. 8 . At cell-survival levels below 10-1 the estimated mean Td for CCNU was about 1 2 days, and that for CY about 2-4 days. At higher levels of cell survival, the estimated mean Td approached the volume-doubling time of control tumours, which was 3 days (i.e. T4x/2). The repopulation studies reported here were found to confirm that cellular repopulation is more rapid after treatment with CCNU than after CY. The results presented here emphasize the complexity of the relationship between tumour-cell kill and growth delay (see also McNally, 1973 McNally, ,1975a McNally, , 1975b Twentyman, 1977) . It would appear that the estimation of cell kill from tumour-growth delay data might be very difficult, although this has been attempted by Lloyd (1975) and by Griswold (1975) . They made the assumption that cellular repopulation after treatment occurs at the same rate as the growth of an equal-sized population of untreated cells. This assumption is clearly suspect, and may explain why Lloyd's estimated values for cell kill after treatment of B16 melanoma with CCNU and MeCCNU appeared to be lower than was obtained by direct bioassay. Griswold's estimates of cell kill in B16 melanoma following treatment with MeCCNU were also much lower than the values obtained by Blackett, Courtenay and Mayer (1975) using a colony assay. Griswold also obtained much higher estimates of cell kill by CY than we have observed in this study. These results may be explained, if the repopulation rate assumed by Griswold was underestimated after MeCCNU treatment but overestimated after CY. The reason for the more rapid repopulation after treatment with CCNU than after CY, reported here, is under investigation. Possible explanations being considered include inherent changes following treatment, in the intermitotic time of surviving cells, the degree of damage to the tumour matrix, the nutritional status of animals and the immunological response.
